Verrica Pharmaceuticals Inc.
VRCA
Revenue
5.18M
▲1.35M▲35.31%
3 Months ChangeAssets
52.01M
▼-14.30M▼-21.56%
3 Months ChangeLiabilities
65.31M
▲511.00k▲0.7886%
3 Months ChangeFree Cash Flow
-19.95M
▼-15.35M▼-333.54%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-08
Form 8-K
ID: 0001193125-24-234391
2024-10-01
Form 8-K
ID: 0001193125-24-230240
2024-09-27
Form 8-K
ID: 0001193125-24-227975
2024-09-06
Form 8-K
ID: 0001193125-24-215180
2024-08-27
Form 8-K
ID: 0001193125-24-207814
2024-08-14
Form 10-Q
ID: 0000950170-24-096669
2024-08-14
Form 8-K
ID: 0001193125-24-200247
2024-08-05
Form 8-K
ID: 0001193125-24-193923
2024-06-28
Form 8-K
ID: 0001193125-24-172277
2024-06-10
Form 8-K
ID: 0001193125-24-158353